Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
2.000
-0.060 (-2.91%)
Apr 16, 2026, 12:16 PM EDT - Market open
Neumora Therapeutics Market Cap
Neumora Therapeutics has a market cap or net worth of $364.08 million as of April 16, 2026. Its market cap has increased by 124.77% in one year.
Market Cap
364.08M
Enterprise Value
247.48M
1-Year Change
124.77%
Ranking
Category
Stock Price
$2.00
Market Cap Chart
Since the IPO on September 15, 2023, Neumora Therapeutics's market cap has decreased from $2.58B to $364.08M, a decrease of -85.91%. That is a compound annual growth rate of -53.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 375.00M | 23.28% |
| Dec 31, 2025 | 304.19M | -82.24% |
| Dec 31, 2024 | 1.71B | -34.22% |
| Dec 29, 2023 | 2.60B | 0.79% |
| Sep 15, 2023 | 2.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| X4 Pharmaceuticals | 392.77M |
| Palisade Bio | 389.26M |
| Zentalis Pharmaceuticals | 386.57M |
| Monopar Therapeutics | 385.13M |
| YD Bio | 381.49M |
| Puma Biotechnology | 380.56M |
| Niagen Bioscience | 379.97M |
| Cabaletta Bio | 377.94M |